AstraZeneca to Test Combination of Its Own Vaccine With Russia's Sputnik V
11 Dezember 2020 - 12:08PM
Dow Jones News
By Matteo Castia
AstraZeneca PLC said Friday that it will collaborate with
Russia's Gamaleya Research Institute to combine its own vaccine
candidate with Gameleya's Sputnik V vaccine.
The pharmaceutical group said repeated administration of a
vaccine is likely to boost immunization efficacy, both in case of
multiple shots of the same vaccine or combining different ones.
The company said it is therefore exploring ways to assess
heterologous combinations of different vaccines, including
cooperating with the Gamaleya Research Institute to understand
whether two adenovirus-based vaccines can be successfully
combined.
AstraZeneca said assessing different types of Covid-19 vaccines
in combination could help unlock synergies in protection and
improve vaccine accessibility.
"It is clear that to overcome the Covid-19 pandemic, more than
one vaccine will be needed," it added.
Write to Matteo Castia at matteo.castia@dowjones.com
(END) Dow Jones Newswires
December 11, 2020 05:53 ET (10:53 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
